Editorial: dynamic changes of the inflammation‐based index predict mortality following chemoembolisation for hepatocellular carcinoma – authors' reply

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|41|11|1218-1219

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.11, 2015-06, pp. : 1218-1219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: dynamic changes of the inflammation‐based index predict mortality following chemoembolisation for hepatocellular carcinoma

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 11, 2015-06 ,pp. : 1216-1217

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: hepatocellular carcinoma ‐ a rare complication of hepatic venous outflow tract obstruction – authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 11, 2015-06 ,pp. : 1213-1214

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: diabetes and its association with hepatocellular carcinoma in chronic hepatitis B – authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 1, 2015-07 ,pp. : 118-119

John Wiley & Sons Inc

Access to resources Recommend Favorite

The preoperative globulin‐to‐albumin ratio, a novel inflammation‐based prognostic system, predicts survival after potentially curative liver resection for patients with hepatocellular carcinoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 116, Iss. 8, 2017-12 ,pp. : 1166-1175

John Wiley & Sons Inc

Access to resources Recommend Favorite

HCC O‐23: Outcome of patients with hepatocellular carcinoma treated with transarterial chemoembolisation

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 13-14

John Wiley & Sons Inc

Access to resources Recommend Favorite